首页|血清NSE、PTX3表达与缺血性脑卒中患者阿替普酶静脉溶栓后神经功能恢复情况的关系探究

血清NSE、PTX3表达与缺血性脑卒中患者阿替普酶静脉溶栓后神经功能恢复情况的关系探究

扫码查看
目的 观察缺血性脑卒中患者血清神经元特异性烯醇化酶(NSE)、正五聚蛋白3(PTX3)表达及神经功能恢复情况,分析血清NSE、PTX3表达与神经功能恢复的关系,已期为临床促进患者神经功能恢复提供靶点参考。方法 将2023年1月至2024年1月此期间收治的缺血性脑卒中患者纳入研究,纳入对象均开展阿替普酶溶栓治疗,检测患者溶栓前血清NSE、PTX3表达,依据美国国立卫生院卒中量表(NIHSS)评分评价老年患者的神经功能恢复情况,与溶栓前相比,将溶栓后NIHSS得分减少≥45%的患者纳入恢复良好组,NIHSS得分减少<45%纳入恢复不良组,分析血清NSE、PTX3表达与神经功能恢复情况的关系。结果 入组100例缺血性脑卒中患者阿替普酶溶栓治疗后,基本痊愈62例,显著有效10例,将上述72例患者纳入恢复良好组,有效15例,无变化13例,将28例患者纳入恢复不良组。相较于恢复不良组,恢复良好组患者血清PTX3、NSE表达较低,NIHSS量表得分较低,差异均有统计学意义(P<0。05);经多元Logistic回归模型结果显示,溶栓前血清PTX3、NSE表达与患者溶栓治疗后神经功能恢复情况有关,血清PTX3、NSE过表达可能是导致缺血性脑卒中患者阿替普酶溶栓治疗后神经功能恢复不良的危险因素(OR>1,P<0。05);绘制ROC曲线,结果显示,溶栓前血清PTX3、NSE表达单独、联合预测患者溶栓后神经功能恢复不良的AUC均>0。80,联合预测价值较理想。依据ROC曲线得出溶栓前血清PTX3≥1。565(μg/L)、NSE≥27。160(μg/L)时,缺血性脑卒中患者溶栓治疗后神经功能恢复不良风险较高;经相关性分析显示,缺血性脑卒中患者溶栓前血清PTX3、NSE表达与溶栓后NIHSS均呈正相关(P<0。05)。结论 缺血性脑卒中患者阿替普酶溶栓前血清PTX3、NSE表达与溶栓后神经功能恢复情况密切相关,溶栓前血清PTX3、NSE过表达可能是导致患者溶栓后神经功能恢复不良的危险因素。
The relationship between the expression of serum NSE and PTX3 and the recovery of neurological function in patients with ischemic stroke after intravenous thrombolysis with alteplase
Objective To observe the expression of serum neuron-specific enolase(NSE)and pentraxin 3(PTX3)and neurological recovery in patients with ischemic stroke,and to analyse the relationship between the expression of se-rum NSE and PTX3 and neurological recovery,with the aim of providing a target point of reference to clinically pro-mote the recovery of neurological function in patients.Methods Ischemic stroke patients admitted between January 2023 and January 2024 were included in the study,and all of them underwent thrombolytic treatment with alteplase,and the expression of serum NSE and PTX3 before thrombolysis was detected,and the neurological recovery of elderly pa-tients was evaluated according to the score of the National Institutes of Health Stroke Scale(NIHSS),and patients with≥45%decrease in NIHSS score after thrombolysis were included in the study.Compared with pre-thrombolysis,pa-tients with ≥45%reduction in NIHSS score after thrombolysis were included in the good recovery group,and those with<45%reduction in NIHSS score were included in the poor recovery group,and the relationship between serum NSE,PTX3 expression and neurological recovery was analysed.Results After thrombolytic treatment with alteplase in 100 ischaemic stroke patients enrolled,62 cases were basically cured,10 cases were significantly effective,and the above 72patients were included in the good recovery group,15 cases were effective,13 cases were unchanged,and 28 patients were included in the poor recovery group.Compared with the poor recovery group,patients in the good recovery group had lower serum PTX3 and NSE expression and lower NIHSS scale scores,and the differences were statistically signifi-cant(P<0.05);the results of the multivariate logistic regression model showed that the expression of serum PTX3 and NSE prior to thrombolysis was related to the recovery of neurological function after thrombolysis,and that the overex-pression of serum PTX3 and NSE might be the cause of ischaemic stroke.is a risk factor for poor neurological recovery after thrombolysis with alteplase in patients with ischemic stroke(OR>1,P<0.05);ROC curves were plotted,and the results showed that the AUCs of pre-thrombolysis serum PTX3 and NSE expression alone and in combination predicted the poor neurological recovery after thrombolysis in patients with ischemic stroke were both>0.80,and the combined predictive value was more desirable.According to the ROC curve,the risk of poor neurological recovery after thrombol-ysis in ischemic stroke patients was higher when the pre-thrombolysis serum PTX3≥1.565(μg/L)and NSE≥27.160(μg/L);correlation analysis showed that the pre-thrombolysis serum PTX3 and NSE expression in ischemic stroke pa-tients were positively correlated with the post-thrombolysis NIHSS(P<0.05).Conclusion Serum PTX3 and NSE ex-pression before thrombolysis by alteplase in ischemic stroke patients is closely related to the recovery of neurological function after thrombolysis,and overexpression of serum PTX3 and NSE before thrombolysis may be a risk factor lead-ing to poor neurological function recovery after thrombolysis in patients.

Ischaemic strokeNeuron-specific enolaseProtein 3Neurological functionAlteplaseIntravenous thrombolysis

王景景、霍姝峰

展开 >

核工业二一五医院临床药学室,陕西咸阳 712000

延安大学咸阳医院神经内科,陕西咸阳 712000

缺血性脑卒中 神经元特异性烯醇化酶 正五聚蛋白3 神经功能 阿替普酶 静脉溶栓

2024

中国实验诊断学
吉林大学中日联谊医院 上海交通大学医学院附属瑞金医院

中国实验诊断学

CSTPCD
影响因子:1.273
ISSN:1007-4287
年,卷(期):2024.28(12)